Nanobiotix SA Sponsored ADR NBTX 深 沪
已收盘 02-06 16:00:00 美东时间
20.85
-0.180
-0.86%
华盛通- 最 高21.70
- 今 开21.18
- 成交量 6301股
- 最 低 20.71
- 昨 收 21.03
- 总市值 10.09亿
- 52周最高 30.35
- 市盈率 静 --
- 换手率 0.01%
- 52周最低 2.95
- 委 比 41.18%
- 总股本 4838.80万
- 历史最高 30.35
- 量 比 0.48
- 振 幅 4.71%
- 历史最低 1.75
- 每 手 1
- 风险率 8.18%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Guggenheim Maintains Buy on Nanobiotix, Raises Price Target to $26
Guggenheim analyst Michael Schmidt maintains Nanobiotix (NASDAQ:NBTX) with a Buy and raises the price target from $8 to $26.
02-06 22:40
Outset Medical, Gemini Space Station, CoreWeave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures were mostly lower this morning, with the S&P 500 futures...
2025-11-11 21:29
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Alphatec Holdings (NASDAQ:ATEC) shares rose 21.7% to $19.88 during Fri...
2025-10-31 20:10
Nanobiotix And HealthCare Royalty Ink 71M Non-Dilutive Financing Agreement To Support JNJ-1900 (NBTXR3) Development And Long-Term Growth
$71 million in funding would extend Nanobiotix cash visibility into early 2028Transaction enables Nanobiotix development beyond key milestones in head and neck cancer and lung cancerFinancing establishes financial
2025-10-31 15:18
Wayfair, Qorvo, Celestica, United Parcel Service, Regeneron Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Dow Jones index gaining around 200 points on ...
2025-10-28 22:14
NANOBIOTIX Announces Updates to JNJ-1900 (NBTXR3) Clinical Program Following Transfer of Ongoing Phase 3 Head and Neck Cancer Trial Sponsorship and Operational Control
Nanobiotix announced the completion of transferring sponsorship and operational control of the NANORAY-312 clinical trial for JNJ-1900 (NBTXR3) to Johnson & Johnson. Interim data analysis is expected in 1H2027 after recruitment and requisite events. Nanobiotix will continue to provide updates on its sponsored studies and collaborations. JNJ-1900, a novel oncology product, is activated by radiotherapy and has shown potential in treating solid tumo...
2025-10-24 06:00
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining aroun...
2025-10-20 20:10
Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Dow Jones index gaining around 100 points on ...
2025-10-08 22:39
Nanobiotix SA ADR Reports Revenue Surge Amid Strategic Advances
Nanobiotix Sa ADR ( ($NBTX) ) has released its Q2 earnings. Here is a breakdown...
2025-10-04 11:50
Nanobiotix S.A. GAAP EPS of -€0.11, revenue of €26.6M
Nanobiotix S.A. press release (OTC:NNBXF): 1H GAAP EPS of -€0.11. Revenue of €26.6M. More on Nanobiotix Nanobiotix: Today's Data Readout For Radiation Therapy Enhances Bull Case Nanobiotix S.A. (NBTX)...
2025-10-01 22:07
